Benefits
Provides prolonged skeletal muscle relaxation
Facilitates safe and controlled intubation
Suitable for long-duration surgical procedures
Supports mechanical ventilation management
USP-compliant quality assurance
Usage Instructions
Administered intravenously or intramuscularly by a qualified healthcare professional
Dosage depends on age, body weight, and clinical condition
Do not exceed recommended daily dosage
For professional medical use only
Mechanism of Action
Pancuronium Bromide works by competitively blocking acetylcholine at nicotinic receptors at the neuromuscular junction. This prevents nerve impulse transmission to skeletal muscles, resulting in temporary muscle paralysis.
Indications
Pancuronium Bromide Injection USP 4 mg/2 mL is indicated for:
Adjunct to general anesthesia to facilitate endotracheal intubation
Providing skeletal muscle relaxation during surgical procedures
Support for mechanical ventilation in intensive care settings
Long-duration neuromuscular blockade during operative procedures
Side Effects
Possible side effects may include:
Increased heart rate (tachycardia)
Elevated blood pressure
Prolonged muscle weakness
Injection site reactions
Rare: Severe allergic or anaphylactic reactions
Precautions
Use only in facilities equipped for airway management and resuscitation
Monitor cardiovascular and respiratory function continuously
Use cautiously in patients with renal or hepatic impairment
Dose adjustment may be required in elderly or debilitated patients
Reversal agents should be readily available
Contraindications
Known hypersensitivity to pancuronium bromide or other neuromuscular blocking agents
Use without adequate facilities for airway management and ventilatory support
Patients with severe myasthenia gravis (use with extreme caution)